Please login to the form below

Not currently logged in


This page shows the latest FDA news and features for those working in and with pharma, biotech and healthcare.

FDA clears Sandoz and Pear’s Opioid Use Disorder app

FDA clears Sandoz and Pear’s Opioid Use Disorder app

The app incorporates CBT to improve high relapse rates. The FDA has approved the use of a mobile phone app to help those with Opioid Use Disorder (OUD), a follow up ... McCann added: “This ground breaking decision by the FDA ushers in a new standard

Latest news

More from news
Approximately 561 fully matching, plus 2,295 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 2 fully matching, plus 102 partially matching documents found.

Latest appointments

More from appointments
Approximately 6 fully matching, plus 41 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 33 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company

We're a healthcare communications agency that does things differently. We put patients at the heart of everything we do, while...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...